Évolution de la prescription de prévention secondaire chez les coronariens après revascularisation : enquête ANCOR (Analyse nationale de la prise en charge de la maladie coronaire avant et après revascularisation)-Reference-Cited by-同舟云学术

Évolution de la prescription de prévention secondaire chez les coronariens après revascularisation : enquête ANCOR (Analyse nationale de la prise en charge de la maladie coronaire avant et après revascularisation)

Published:2005-08 Issue:4 Volume:54 Page:184-189
ISSN:0003-3928
Container-title:Annales de Cardiologie et d'Angéiologie
language:fr
Short-container-title:Annales de Cardiologie et d'Angéiologie

Author:

Jullien G.,Mosnier M.,Danchin N.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference16 articles.

1. Use of secondary preventive drugs in patients with acute coronary syndromes treated medically or with coronary angioplasty: results from the nationwide French PREVENIR survey;Danchin;Heart,2002

2. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in 9 countries;Lancet,2001

3. ACC/AHA 2002 Guideline Update for the Management of Patients With Chronic Stable Angina—Summary Article

4. Primary care management of chronic stable angina and asymptomatic suspected or known coronary artery disease: a clinical practice guideline from the American College of Physicians;Snow;Ann. Intern. Med.,2004

5. Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention. A randomized controlled trial;Serruys;JAMA,2002

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of recommended medications after myocardial infarction in Austria;European Journal of Epidemiology;2007-12-07

2. La prise en charge des patients souffrant d’une maladie coronaire en France en 2004;La Presse Médicale;2006-08